Umbilical cord blood-derived therapy for preterm lung injury: a systematic review and meta-analysis.
Elisha PurcellJainam ShahCameron PowellTimothy NguyenLindsay ZhouCourtney A McDonaldBeth J AllisonAtul MalhotraPublished in: Stem cells translational medicine (2024)
Administration of UCB-derived therapy was associated with statistically significant improvements across several lung injury markers in preclinical studies. Early clinical studies demonstrated the administration of UCB-derived therapy as safe and feasible but lacked data regarding efficacy.